It also downregulates the levels of cyclin D1, CDK4, and pRB, and upregulates the levels of E2F mRNA and tumor suppressor p21, independently of p53, leading to epigenetic modifications in the regulation of cancer cell senescence [125]. This evidence concerns the gene TP53 and cancer.